Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goodman-Meza

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Plos One|December 22, 2020
Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort studyAna C Monteiro, Rajat Suri, Iheanacho O Emeruwa, et al.
AIDS and Behavior|September 5, 2022
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction MedicineGabriel G Edwards, Ayako Miyashita-Ochoa, Enrico G Castillo, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|November 22, 2015
Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?Jorge Romero, Samuel H Baldinger, David Goodman-Meza, et al.
Trials|February 15, 2024
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)David Goodman-Meza, Steven Shoptaw, Brett Hanscom, et al.
Drug and Alcohol Review|June 20, 2026
Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploration With HIV Prevention Trials Network 094 INTEGRA Participants and StaffRose A Schmidt, Amaya Perez-Brumer, Peter Davidson, et al.
International Journal of Cardiology|June 14, 2017
Atrial fibrillation inducibility during cavo-tricuspid isthmus dependent atrial flutter ablation for the prediction of clinical atrial fibrillationJorge Romero, Rodolfo Estrada, Anthony Holmes, et al.
ACS Nano|June 23, 2021
Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody ResponsesF Javier Ibarrondo, Christian Hofmann, Jennifer A Fulcher, et al.
Plos One|September 22, 2020
A machine learning algorithm to increase COVID-19 inpatient diagnostic capacityDavid Goodman-Meza, Akos Rudas, Jeffrey N Chiang, et al.
JAMA Network Open|February 5, 2026
Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject DrugsNabila El-Bassel, Steven Shoptaw, Timothy Skalland, et al.
Trials|April 29, 2026
Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic riskPhyo Pyae Nyein, Hila Haskelberg, Marianne Martinello, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Plos One|December 22, 2020
Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort studyAna C Monteiro, Rajat Suri, Iheanacho O Emeruwa, et al.
AIDS and Behavior|September 5, 2022
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction MedicineGabriel G Edwards, Ayako Miyashita-Ochoa, Enrico G Castillo, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|November 22, 2015
Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?Jorge Romero, Samuel H Baldinger, David Goodman-Meza, et al.
Trials|February 15, 2024
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)David Goodman-Meza, Steven Shoptaw, Brett Hanscom, et al.
Drug and Alcohol Review|June 20, 2026
Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploration With HIV Prevention Trials Network 094 INTEGRA Participants and StaffRose A Schmidt, Amaya Perez-Brumer, Peter Davidson, et al.
International Journal of Cardiology|June 14, 2017
Atrial fibrillation inducibility during cavo-tricuspid isthmus dependent atrial flutter ablation for the prediction of clinical atrial fibrillationJorge Romero, Rodolfo Estrada, Anthony Holmes, et al.
ACS Nano|June 23, 2021
Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody ResponsesF Javier Ibarrondo, Christian Hofmann, Jennifer A Fulcher, et al.
Plos One|September 22, 2020
A machine learning algorithm to increase COVID-19 inpatient diagnostic capacityDavid Goodman-Meza, Akos Rudas, Jeffrey N Chiang, et al.
JAMA Network Open|February 5, 2026
Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject DrugsNabila El-Bassel, Steven Shoptaw, Timothy Skalland, et al.
Trials|April 29, 2026
Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic riskPhyo Pyae Nyein, Hila Haskelberg, Marianne Martinello, et al.
Pageof 9